Prospective Evaluation of Adventitial Histopathology in Borderline Ascending Aortic Dilatatio
Key facts
- Who runs it
- Samsun University
- Where
- Türkiye1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 130 people enrolled
- Started
- 1 Aug 2023
- Ended
- 30 Jun 2026
- Type of study
- Observational, 2 groups
- Record updated
- 18 November 2026
Who can take part
- Age
- 18 years to 70 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- Adults aged between 18 and 70 years
- Patients scheduled for elective open-heart coronary artery bypass grafting (CABG)
- Patients undergoing their first cardiac surgery
- Metabolically stable patients
- Aortic diameter:; Observational aortic dilatation group: between 4.0 cm and 5.0 cm; Control group: less than 4.0 cm
- Written informed consent obtained from the patient
Who cannot take part
- History of previous cardiac surgery
- Patients not undergoing any aortic intervention during surgery
- History of aortic dissection or rupture
- Known genetic syndromes (e.g., Marfan, Loeys-Dietz, Ehlers-Danlos)
- Presence of acute infection or systemic inflammatory disease
- Known systemic vasculitis
- Inadequate biopsy material for pathological analysis
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This prospective study investigates microscopic changes in the outer layer (adventitia) of the ascending aorta in patients undergoing coronary artery bypass grafting (CABG) surgery. The study includes two groups of patients: (1) those with borderline ascending aortic dilatation (4.0-5.0 cm), and (2) a control group with normal aortic diameter (<4.0 cm), all undergoing the same surgical procedure. During CABG, a small circular punch is routinely made in the ascending aorta for the proximal saphenous vein graft anastomosis. The tissue removed from this punch site is collected and used for histopathological and immunohistochemical analysis. The study aims to determine whether adventitial changes correlate with aortic size and whether these changes can help identify patients at risk for future aortic dissection or rupture. The findings may guide surgical decision-making in patients with borderline aortic enlargement.
The 2 groups in the trial
- Observational Aort Dilated Group
Patients undergoing elective coronary artery bypass grafting (CABG) with an ascending aortic diameter between 4.0 cm and 5.0 cm. These patients do not have known genetic aortopathy and are undergoing their first cardiac surgery. Aortic tissue samples are collected during surgery from the punch biopsy site used for proximal anastomosis.
- Observational Control Group
Patients undergoing elective CABG with an ascending aortic diameter less than 4.0 cm. These patients also do not have known aortopathies and are undergoing their first cardiac surgery. Punch biopsy material is similarly collected for histopathological evaluation.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Prospective Analysis of Adventitial Pathology in Patients Undergoing Coronary Bypass With Borderline Ascending Aortic Dilatation
- Record updated
- 18 November 2026